ATMA’s Phase II Psilocybin-assisted Therapy Clinical Trial has now received a No Objection Letter from Health Canada, as well as approval from the Health Research Ethics Board of Alberta. As such, we are now beginning preparations for the screening and enrollment process. We anticipate recruitment will begin within several months, and we will be posting details regarding these dates as soon as possible. In the meantime, you can find more information at www.atmajourney.com/clinical-trials, including details outlining the processes and eligibility criteria for the Phase II Psilocybin-assisted Therapy Clinical Trial.
Bring your questions on June 6th at 6PM MDT for an online townhall where we will address the status of the clinical trial and discuss opportunities for participation as volunteer staff, participant, or observer.
BACK TO TOP